Black people with multiple sclerosis (MS) may face higher mortality rates and more severe symptoms than white people, yet 98% of participants in recent MS drug trials were white. This lack of ...

NASHVILLE, Tennessee — For the first time, the majority of patients with multiple sclerosis (MS) in the United States are, or soon will be, over age 55, a phenomenon that's driving a shift in ...

NEW YORK--(BUSINESS WIRE)--The Tisch MS Research Center of New York (MSRCNY), the world’s largest independent research center focused on multiple sclerosis, has published new research finding that ...

In MS, immune system cells mistakenly attack myelin. With stem cell treatment, doctors use chemotherapy to destroy these existing immune cells. Then, they introduce the new stem cells, which are not ...

Epstein-Barr virus (EBV)-positive infectious mononucleosis was linked to a more than threefold increase in MS risk. The study analyzed people with infectious mononucleosis who had lab confirmation ...

Speakers at the Americas Committee for Treatment and Research in Multiple Sclerosis Forum 2024 focused their attention on avenues to improve research accessibility for investigators and care access ...

-- for advancing our understanding of immune mechanisms underlying multiple sclerosis and translating them to develop innovative strategies to treat the disease Roland Martin, MD, a world-class ...

The poster session at the Americas Committee for Research and Treatment in Multiple Sclerosis (ACTRIMS) Forum 2024 dedicated a section to emerging developments in the use of artificial intelligence ...

Multiple sclerosis research focuses on the early years of life by Friederike Fellenberg, NAKO e.V. / NAKO Gesundheitsstudie edited by Sadie Harley, reviewed by Robert Egan Editors' notes The GIST ...

A new multiple sclerosis (MS) research project designed to help the brain repair itself by activating its own healing processes has been announced as part of MS Australia's latest $5.7 million ...

West Palm Beach, Florida — Migraine, a common comorbidity in multiple sclerosis (MS) is not part of the MS prodrome, new research suggested. Investigators found that patients with MS were more likely ...

While age at diagnosis may influence the rate of MS progression, it appears not to be the only factor.